Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02688959 · ClinicalTrials.gov registry record · NA

Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
NA
Development phase
145
Enrollment target
1
Study location

NCT02688959: Recruiting NA study of Attention Deficit Hyperactivity Disorder, sponsored by University of Wisconsin, Madison.

NCT02688959 is a NA study of Attention Deficit Hyperactivity Disorder that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 145 participants, below the 215-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02688959, a NA study of Attention Deficit Hyperactivity Disorder, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
NA
Development phase
145 participants
Enrollment target
1
Study location

Study Summary

The investigators will perform a feasibility/pilot trial of two non-pharmacological interventions for ADHD in college students.

Primary Outcome

Inattentive Symptoms subscale of the Conners Adult ADHD Rating Scale self-report long form (CAARS-S:L). The total range of scores is 0-27 with higher scores indicating more severe symptom levels.

Interventions

  • BEHAVIORAL Exercise
  • BEHAVIORAL Tai Chi

Study Locations (1)

Wisconsin

  • University of Wisconsin-Madison, Waisman Center - Madison

Trial Details

FieldValue
Enrollment Target 145 participants
Start Date 2016-02
Est. Completion 2028-12
Phase NA
University of Wisconsin, Madison

1,039 total trials

What NCT02688959 shows while recruiting

NCT02688959 is an interventional study that assigns participants to a tested intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 215-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (33% lower).

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.

NCT02688959 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT02688959 about?

NCT02688959 is a clinical study titled "Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)". The investigators will perform a feasibility/pilot trial of two non-pharmacological interventions for ADHD in college students.

What is the current status of trial NCT02688959?

This trial is currently recruiting. It is a NA study. The enrollment target is 145 participants. The study started on 2016-02. Estimated completion is 2028-12.

What conditions does trial NCT02688959 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT02688959?

The interventions under investigation include: Exercise (BEHAVIORAL), Tai Chi (BEHAVIORAL).

Who is sponsoring clinical trial NCT02688959?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02688959 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02688959's enrollment target sits among peer trials

145 37th of 102 higher than 66 of 102 other Attention Deficit Hyperactivity Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03586609 · 145 participants · Phase 2

    Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia

  • NCT03767595 · 145 participants · NA

    ProACT Post-Approval Study

  • NCT03808337 · 145 participants · Phase 2

    Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

  • NCT04900623 · 145 participants · Phase 2

    Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02688959, the US trial registry maintained by the National Library of Medicine. NCT02688959 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.